`

Adamis Pharmaceuticals Corporation

Sign Up to View More
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$8.0M
size-icon Size
11 - 50
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About Adamis Pharmaceuticals Corporation

What does Adamis pharmaceuticals corporation do?+

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) is a specialty biopharmaceuticals company primarily focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease. The Companys SYMJEPI (epinephrine) Injection products are approved by the FDA for use in the emergency treatment of acute allergic reactions, including anaphylaxis. The Companys ZIMHI (naloxone) Injection product is approved for the treatment of opioid overdose. Tempol is in development for the treatment of patients with COVID-19 and a Phase 2/3 clinical trial is underway. https://www.adamispharmaceuticals.com/social-media

What is Adamis pharmaceuticals corporation's revenue? +

Adamis pharmaceuticals corporation's revenue is 11m - 100m

What is Adamis pharmaceuticals corporation's company size? +

Adamis pharmaceuticals corporation has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free